A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Upadacitinib Impurity 93 - Request Quote

Picture of Upadacitinib Impurity 93

Upadacitinib Impurity 93

SZ CAT No:SZ-U005108
CAS No
NA
Mol.F.
C17H25NO3
Mol.Wt.
291.4
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Upadacitinib Impurity 93 is chemically Benzyl (3S,4R)-3-ethyl-4-(2-hydroxypropan-2-yl)pyrrolidine-1-carboxylate. Upadacitinib Impurity 93 is supplied with detailed characterization data compliant with regulatory guideline. Upadacitinib Impurity 93 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Upadacitinib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Upadacitinib Impurity 93

Purchase Upadacitinib Impurity 93

Upadacitinib Impurity 93 suppliers

Upadacitinib Impurity 93 manufacturers

Upadacitinib Impurity 93 price

Order Upadacitinib Impurity 93

Enquire Upadacitinib Impurity 93

Upadacitinib Impurity 93 cost

Upadacitinib Impurity 93 Supplier

Upadacitinib Impurity 93 Distributor

Upadacitinib Impurity 93 for Method Validation

Upadacitinib Reference Standard

Upadacitinib Impurity 93 for ANDA Filing

Upadacitinib Impurity 93 for Forced Degradation Studies

Upadacitinib Impurity 93 Identification Standards

Upadacitinib Impurity 93 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,